Skip to content
Listen

National Institute on Drug Abuse (NIDA) grant awarded to Shriver Researcher

David Kennedy

Congratulations to Shriver’s own David N. Kennedy, PhD on his recent grant award  from the National Institute on Drug Abuse (NIDA). The grant is designed to develop an “ABCD-ReproNim Course” that provides training for reproducible analyses of the Adolescent Brain Cognitive Development (ABCD) Study® data. Reproducible data analysis, as applied to neuroimaging, has been a longtime professional research interest of Dr. Kennedy. Dr. Kennedy leads ReproNim: A Center for Reproducible Neuroimaging Computation, a National Institute of Biomedical Imaging and Bioengineering (NIBIB) funded biomedical technology research center. The Center’s mission is to improve the reproducibility of neuroimaging science and extend the value of our national investment in neuroimaging research, while making the process easier and more efficient for investigators.

The Adolescent Brain Cognitive Development (ABCD) Study® is the largest long-term study of brain development and child health in the United States, and, is following 10,000 ten year olds for the next 10 years. The ABCD study looks at the development of physical, cognitive, social, emotional, environmental, behavioral, and academic assessments, as well as multimodal neuroimaging and biospecimen collection for hormonal, genetic, epigenetic, environmental exposure, and substance use analysis. Along with Dr. Kennedy’s Co-PI Angela Laird, PhD from Florida International University, the project also brings together research leaders from the Massachusetts Institute of Technology, Canada’s McGill University and 18 instructors from institutions worldwide. For more information on Dr. Kennedy’s ABCD study, visit: https://www.abcd-repronim.org/